Brind.
  1. Medicus Pharma acquired 98.6% of Antev shares on September 2, 2025. The event also noted that Patrick J. Mahaffy was the former CEO of Clovis Oncology.

Medicus Pharma appointed a Chief Medical Officer to lead Antev Limited's clinical program.

1 report, 1 independent Updated Aug 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Medicus Pharma appointed a Chief Medical Officer to lead Antev Limited's clinical program.

Keep exploring

Part of

Medicus Pharma acquired 98.6% of Antev shares on September 2, 2025. The event also noted that Patrick J. Mahaffy was the former CEO of Clovis Oncology. All 1 developments

Coverage

Newest first; wire copies grouped